T1	Treatment 0 10	Mexiletine
T2	Treatment 146 156	mexiletine
T3	Treatment 417 427	mexiletine
T4	Treatment 499 652	receive mexiletine (maximum dose, 600 mg/day) or placebo for 6 weeks, followed by the alternative intervention for 6 weeks after a 1-week washout period.
T5	Treatment 681 843	assessed using a visual analogue scale card in 19 patients who received at least 2 weeks of the drug, 16 of whom were crossed-over to receive the alternate agent.
T6	Treatment 952 962	mexiletine
T7	Treatment 1174 1184	mexiletine
T8	Treatment 1217 1224	placebo
T9	Treatment 1287 1294	placebo
T10	Treatment 1452 1462	mexiletine
T11	Treatment 1470 1478	placebo.
T12	Treatment 1543 1553	mexiletine
T13	Treatment 1592 1600	placebo.
T14	Treatment 1601 1611	Mexiletine
